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Exposure to second hand smoke is a major cause of chronic obstructive pulmonary
disease (COPD) in the non-smoker. In this review we explore the use of animal smoke
exposure models and their insight into disease pathogenesis. The methods of smoke
exposure, including exposure delivery systems, are described. Key findings from the
acute and chronic smoke exposure models are outlined, including descriptions of the
inflammation processes, proteases involved, oxidative stress, and apoptosis. Finally,
alternatives to rodent models of lung disease are presented.
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INTRODUCTION
Chronic obstructive pulmonary disease (COPD) is a major cause
of disability and death worldwide, with a prevalence estimated at
10% of the general population and up to 50% in heavy smok-
ers (Rennard and Vestbo, 2006). As the incidence of COPD rises,
associated health care costs will increase as well. Exposure to
tobacco smoke is a key etiologic agent of this disease, which is
characterized by progressive airflow limitation with an abnor-
mal inflammatory response in the small airways and alveoli. The
inflammation induced by cigarette smoke leads to an increase in
protease production, a major contributor to the lung destruction
seen in emphysema (Churg et al., 2008).
For the past 50 years emphysematous lung destruction was
believed to arise from an imbalance between proteases and anti-
proteases. This theory was originally formulated after it was noted
that smokers with a congenital deficiency of alpha-1-antitrypsin
(α1-AT), leading to unopposed neutrophil elastase activity, had
an increased incidence of emphysema (Laurell and Erickson,
1963). Imbalances between matrix metalloproteinases (MMPs)
and their endogenous inhibitors, tissue inhibitors of metallo-
proteinases (TIMPs), have been identified in emphysema tissues
(Finlay et al., 1997; Hautamaki et al., 1997; Ohnishi et al., 1998;
Imai et al., 2001; Houghton et al., 2006; Lee et al., 2009; Silverman
and Sandhaus, 2009). MMPs are a family of structurally related
zinc-dependent endopeptidases involved in the degradation and
remodeling of the extracellular matrix during a variety of impor-
tant physiological and pathological processes (Visse and Nagase,
2003) including embryological development, angiogenesis, and
wound healing (Chang and Werb, 2001). Studies in our labora-
tory, and others, have shown that cigarette smoke directly induces
expression of MMPs in resident lung cells (Mercer et al., 2004;
Seagrave et al., 2004; Valenca et al., 2004).
Exposure to second hand tobacco smoke is a major risk fac-
tor for the development of COPD in non-smokers. Based upon
plasma cotinine levels, a non-smoker living with a smoker has a
smoke exposure of approximately 1% of that from an individ-
ual actively smoking 20 cigarettes a day (Thompson et al., 1990;
Law and Hackshaw, 1996). Despite the low level of exposure,
those exposed to second hand smoke exhibit increased levels of
elastin degradation products in the serum (Slowik et al., 2011);
these degradation products are chemotactic for macrophages in
the lung, promoting ongoing inflammation, and lung degra-
dation (Houghton et al., 2006). Genetic factors influence the
development of COPD in smokers (Silverman, 2006) and likely
impact the inflammatory response to second hand smoke. It
should be noted that in the developing world, the burning of
biomass fuels for cooking and heating has been implicated in the
development of COPD in non-smoking adults (Da Silva et al.,
2012).
COPD is manifested by several different pathologies: emphy-
sema, small airway remodeling, chronic bronchitis, and pul-
monary hypertension (Wright et al., 2008). Frequent COPD
exacerbations lead to further decline in lung function in patients
with moderate to severe disease (Donaldson et al., 2002). With
variation in pathologies and clinicalmanifestations, no single ani-
mal model can serve as a surrogate to the human disease. The
structural and mechanical changes in animal models of COPD
can be quite mild, but information regarding second hand smoke
exposure can be gained through examination of the appropri-
ate susceptible species and mouse strains. It is essential that
researchers understand the differences in smoke-exposure animal
models in order to better understand the effects of second hand
smoke in humans.
METHODS OF SMOKE EXPOSURE IN ANIMAL MODELS OF
EMPHYSEMA
There are two main systems used for smoke exposure of rodents,
nose-only smoke exposure machines and whole body exposure
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systems (Coggins, 1998). Nose-only smoke systems offer the
advantages of more controlled dosage and exposure as well as
smoke delivery only to the respiratory system. However, this
method of nasal smoke exposure also involves prolonged whole-
body restraint, a known stressor for mice (van Eijl et al., 2006).
The metal nosepieces utilized in the restraining system have
also been associated with severe hypothermia (van Eijl et al.,
2006).
Whole body smoke exposure systems offer several advantages.
Rodents do not require restraint for smoking, but rather are
housed in their usual cages and bedding. They have free access to
food and water for the duration of smoke exposure. In addition,
the setup of most whole body smoke exposure systems allows
for a large number of rodents and small animals to undergo
simultaneous smoke exposure and therefore it is less labor inten-
sive than nose-only systems. On the other hand, the whole body
smoke exposure system is less controlled than the nose-only sys-
tem; though, measurement of total particulate matter can aid in
ensuring steady smoke exposure during animal experiments. In
addition, in whole body smoke exposure systems animals develop
deposits of nicotine and tar on the fur, which can be ingested
through usual grooming behaviors (Mauderly et al., 1989; Wright
et al., 2008). Regardless of the chosen method of smoke expo-
sure, the quality of smoke exposure can be measured through
carboxyhemoglobin and serum cotinine levels (Wright et al.,
2008).
Cigarette smoke, delivered either by nose-only or whole body
exposure systems, is composed of both mainstream and side
stream smoke. Mainstream smoke is derived directly from the
cigarettes during the inhalation phase or puff of the smoke
machine. Side stream smoke refers to the smoke generated from
the lit end of a cigarette in between puffs, and is the main com-
ponent of second hand smoke. In an evaluation of unpublished
work from Phillip Morris in the 1980’s, fresh side stream smoke
is approximately four times more toxic per gram total particu-
late matter than mainstream smoke (Schick and Glantz, 2005).
Aged side stream smoke (over 10 s old) increases the toxicity four-
fold as compared to fresh side stream smoke (Schick and Glantz,
2006). All of these findings are particularly relevant to animal
smoke exposure systems, which utilize both aged side stream and
mainstream smoke.
LESSONS FROM CHRONIC AND ACUTE SMOKE EXPOSURE
STUDIES
In order to develop structural and physiological changes in the
lung consistent with emphysema, investigators undertake long-
term smoke exposure studies. Variation between investigators
exists, but it is generally accepted that in the mouse model,
at least 6 months of smoke exposure is required to produce
structural and physiological changes consistent with emphysema
(Churg et al., 2008). The exception to this is the highly sus-
ceptible A/J strain, which can develop emphysematous changes,
as measured by mean linear intercept, after only 4 months of
smoke exposure (Braber et al., 2011). The literature describing
studies on acute smoke exposure are much more variable with
regards to the exact duration of exposure, ranging from hours
to weeks. Common to all smoke exposure studies in animals
is the development of pulmonary inflammation. However, the
inflammatory cell characteristics vary by the chosen method of
exposure, species, and withinmice based on strains (van der Vaart
et al., 2004).
In both the chronic and acute smoke exposure models, an
increase in the number of alveolar macrophages is induced by
smoke in the bronchoalveolar lavage (BAL) fluid and lung tis-
sue (van der Vaart et al., 2004); increases in neutrophil counts
are more variable. Increased alveolar macrophages in BAL fluid
can be identified immediately following smoke exposure (Ortega
et al., 1992) and persist throughout the duration of the exposure.
Despite the increase in alveolar macrophage numbers, alveo-
lar macrophages from 8-week smoke-exposed mice demonstrate
an attenuation of the inflammatory signaling pathways associ-
ated with bacterial and viral infections, including TNF-α and
IL-6 (Gaschler et al., 2008) and exhibit an impaired phagocytic
activity immediately following smoke exposure (Ortega et al.,
1992).
Early chronic smoke exposure studies in mice focused mainly
on the carcinogenic properties of tobacco smoke. Initial studies
of non-malignant pulmonary abnormalities caused by chronic
smoke exposure focused on alterations in the inflammatory
response. Findings included peribronchiolar and perivascular
accumulations of lymphocytes and macrophages (Matulionis,
1984), with increased macrophage size due to lysosomal abnor-
malities (Matulionis and Simmerman, 1985). Chronic smoke
exposure was also found to reduce antigen-specific T-cell prolif-
erative response in pulmonary associated lymph nodes (Chang
et al., 1990) as well as the phagocytic index of macrophages
(Ortega et al., 1992). Although structural changes in the mouse
lung occur after long-term smoke exposure, it is important to
note that the changes in mice following chronic smoke expo-
sure are still only mild as measured by mean linear intercept
or lung compliance (Foronjy et al., 2005, 2006; Churg et al.,
2008).
With the development of genetically modified animals,
researchers have been able to better define the contribution
of isolated pathways in emphysema pathogenesis, including the
interstitial collagenase MMP-1 (D’Armiento et al., 1992). The
strength of these animal studies was extended when follow-
up studies demonstrated that indeed MMP-1 expression was
increased in the lung parenchyma of patients with emphysema
(Imai et al., 2001) and that cigarette smoke directly induced
expression of MMP-1 in pulmonary small airway epithelial cells.
Building upon the long known association between emphysema
development in smokers and congenital deficiency of α1-AT
(Laurell and Erickson, 1963), Shapiro and colleagues estab-
lished the critical role of MMP-12 (macrophage elastase) in
emphysema development (Hautamaki et al., 1997). Following the
development of the MMP-12 knockout mouse (Shipley et al.,
1996), the group demonstrated that smoke-exposed mice defi-
cient in MMP-12 do not develop parenchymal changes consis-
tent with emphysema (Hautamaki et al., 1997). In addition to
the role of MMP-12 in chronic smoke exposure, MMP-12 is
also involved in the acute inflammatory response by augment-
ing TNF-alpha release from macrophages, causing neutrophil
influx and endothelial activation (Churg et al., 2003). Elastin
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degradation products, by-products of MMP-12 activity, promote
inflammation and ongoing lung degradation (Houghton et al.,
2006).
Other laboratories have built upon the MMP-12 work, doc-
umenting the importance of additional MMPs in emphysema
pathogenesis (Shapiro et al., 2003; Seagrave et al., 2004; March
et al., 2006; Valenca et al., 2006; Foronjy et al., 2008; Vecchio
et al., 2010). Our laboratory has demonstrated that the transgenic
overexpression of MMP-9 in macrophages causes spontaneous
adult-onset emphysema due to elastin degradation (Foronjy et al.,
2008). In contrast, Atkinson and colleagues have shown that the
MMP-9 deficient mouse still develops smoke-induced emphy-
sema (Atkinson et al., 2011). It is likely that in MMP-9 deficient
mice, the presence of other proteases, includingMMP-12, are suf-
ficient to destroy the lung; yet, MMP-9 potentially plays a role in
the destructive process in combination with other proteases.
Beyond the protease/antiprotease hypothesis, transgenic mice
have shed light into additional pathways critical in emphysema
pathogenesis. A substantial quantity of work has been performed
examining the effect of cigarette smoke on inflammatory path-
ways. TNF-alpha is a key pro-inflammatory factor implicated
in emphysema pathogenesis. TNF-alpha receptor 2 plays a crit-
ical role in this proinflammatory pathway, as mice deficient
in the receptor have both attenuated pulmonary inflammation
and emphysema development in the setting of long-term smoke
exposure (D’Hulst et al., 2006). The pro-inflammatory cytokine
IFN-gamma is a potent stimulator of MMP-9 and CCR5 lig-
ands, the expression of which ultimately results in DNA damage,
apoptosis, and emphysema (Ma et al., 2005). The inflammatory
cell surface receptor CX3CR1 is upregulated by cigarette smoke
exposure; expression of CX3CR1 results in the recruitment of
other CX3CR1 positive cells, mainly macrophages and T lympho-
cytes, amplifying the inflammatory response to cigarette smoke
exposure (McComb et al., 2008). Other pathways implicated in
modulation of the inflammatory response in smoke exposure
include protein phosphatase 2A (PP2A) (Wallace et al., 2012),
forkhead box class O 3a (FOXO3) (Hwang et al., 2011), CCR6
(Bracke et al., 2006), and endothelial monocyte-activating protein
2 (EMAPII) (Clauss et al., 2011).
Oxidative stress is another key mediator in emphysema patho-
genesis and the pathways of lung injury (Yao and Rahman, 2011;
Rahman, 2012). The acute smoke exposure model is well-suited
to examine cellular oxidative stress and mechanisms leading to
increased inflammation (Valenca et al., 2008; Richens et al., 2009;
Gould et al., 2010; Geraghty et al., 2011b; Lu et al., 2011). Within
6 h of smoke exposure, evidence of oxidative stress can be detected
within the pulmonary vascular endothelium (Lu et al., 2011).
Many different pathways alter the levels of oxidative stress within
the lung following smoke exposure. Superoxide dismutase (SOD)
is an enzyme that catalyzes the breakdown of superoxide rad-
icals into oxygen and hydrogen peroxide. Our laboratory first
demonstrated a protective role of antioxidants when transgenic
mice expressing elevated levels of SOD in the lung were shown
to be protected from the development of emphysema through
attenuation of the inflammatory response, particularly neutrophil
inflammation after smoke exposure and intratracheal elastase
administration (Foronjy et al., 2006). The loss of antioxidants
were shown by Rahman and colleagues to lead to impaired lung
function and exercise capacity following chronic cigarette smoke
exposure in mice lacking SOD3 (Yao et al., 2010). Moreover,
overexpression of SOD3 as well as exogenous administration of
SOD analogues attenuated emphysema development (Yao et al.,
2010) in smoke exposure models. SOD appears to provide pro-
tective benefits against oxidative stress mediated fragmentation
of the extracellular matrix (Yao et al., 2010). Another interesting
area of research in emphysema relates to endoplasmic reticulum
(ER) stress. In the setting of acute smoke exposure, inflamma-
tory cells, predominately macrophages, develop ER stress through
CHOP induction by cigarette smoke, but during in vivo long-
term smoke exposure, the ER stress response is reduced (Geraghty
et al., 2011b). The finding of decreased ER stress in long-term
smoke exposed mice is analogous to the human disease, where in
human emphysematous lung tissue, there is a decrease in markers
of ER stress (Korfei et al., 2008).
Other critical pathways modulating oxidative stress that were
shown to be important in the smoke exposure model include the
mTOR pathway, where smoke exposure upregulates the mTOR
inhibitor and stress related protein Rtp801, amplifying oxidative
stress, NF-kappa-B activation and subsequent alveolar inflam-
mation and alveolar septal apoptosis (Yoshida et al., 2010).
Nrf2, a regulator of the antioxidant pathway, also plays a major
role in determining susceptibility to smoke-induced emphysema
by upregulating antioxidants and thereby decreasing inflamma-
tion (Rangasamy et al., 2004, 2009; Iizuka et al., 2005; Gebel
et al., 2010). Additionally, the TGF-β signaling pathway influences
oxidative stress in the setting of smoke exposure; antagonism
of this pathway with the angiotensin receptor type 1 blocker
losartan decreased oxidative stress, inflammation and extracel-
lular matrix remodeling (Podowski et al., 2012). Furthermore,
the class III histone/protein deacetylase SIRT1 regulates cigarette
smoke-exposure mediated proinflammatory signaling through
NF-kappa-B and levels are decreased in rats following smoke
exposure (Yang et al., 2007). SIRT1 levels are also decreased in
both macrophages and the lung tissue of smokers and patients
with COPD (Rajendrasozhan et al., 2008). Activation of the
SIRT1 pathway in vitro with resveratrol decreases proinflamma-
tory cytokine release (Yang et al., 2007; Arunachalam et al., 2010),
and both genetic overexpression and pharmacologic activation of
SIRT1 protects against smoke-induced emphysema via a FOXO3-
mediated reduction of cellular senescence independent of the
inflammatory effects (Yao et al., 2012).
The pattern recognition receptor toll-like receptor-4 (TLR4),
mediated through the NADPH oxidase (NOX) pathway, is
another important component in the oxidative stress pathway
critical in emphysema development. Lee and colleagues have
shown that deficiency of TLR4 leads to upregulation of NOX2
in lungs and endothelial cells, causing increased oxidant genera-
tion and elastolytic activity within the parenchyma (Zhang et al.,
2006). TLR4 deficiency also promotes apoptosis and autophagy
in the setting of smoke exposure, with increased airspace enlarge-
ment as compared to smoked wild-type mice (An et al., 2012),
suggesting a protective benefit to TLR4 expression in the lung.
However, TLR4 activation by cigarette smoke also has negative
effects within the lung. Lipopolysaccharide (LPS) is a component
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of cigarette smoke as well as a known TLR4 ligand; activation of
TLR4 leads to IL-1 production, IL-1 receptor 1 signaling, and
downstream inflammation (Doz et al., 2008). Our group has
demonstrated that TLR4 is upregulated within the lungs of both
smoke-exposed mice and rabbits, and have documented increased
signaling through TLR4 in human emphysematous lung tissue
(Geraghty et al., 2011a). When MMP-1 is present, as is seen in
both human emphysema as well as in the smoke-exposed rabbit,
TLR4 activation by cigarette smoke ultimately leads to expression
of the collagenase MMP-1 (Geraghty et al., 2011a). In addition
to the smoking model of emphysema, hyperlipidemia alone, as is
seen in the ApoE knockout mouse fed a high fat diet, is sufficient
to cause peribronchial and perivascular inflammation through
TLR4 activation leading to emphysema development (Goldklang
et al., 2012), suggesting a newmechanism linking emphysema and
cardiovascular disease. The role that this specific pathway plays in
smoke exposure induced emphysema remains to be determined
in future studies.
Finally, apoptosis is an additional critical process in emphy-
sema pathogenesis that has been investigated in the smoke expo-
sure model. Apoptosis is a mechanism of programmed cell death
that occurs during normal lung morphogenesis, but can also
be triggered by multiple stimuli that are pertinent in emphy-
sema development, including loss of contact with the extracellular
matrix, reduction in VEGF signaling, induction by immune cells,
and various stresses including oxidative stress (Morissette et al.,
2009). As mentioned above, the TLR4 pathway modulates both
cellular apoptosis and autophagy in response to chronic cigarette
smoke exposure (An et al., 2012). The ceramide pathway, mod-
ulated by neutral sphingomyelinase 2 (nSMase2) also modulates
cigarette smoke related epithelial cell apoptosis. nSMase is upreg-
ulated in the lung following smoke exposure, while knockdown
of nSMase with a heterozygous mouse decreases smoke related
ceramide production and apoptosis (Filosto et al., 2011). Other
implicated pathways in smoke related emphysema include the
TGF-β signaling pathway via SMAD-3 (Farkas et al., 2011),
cytokine IL-6 (Ruwanpura et al., 2011), VEGF (Kasahara et al.,
2000; Tuder et al., 2003b), and autophagy via early growth
response-1 (Egr-1) and the protein microtubule-associated pro-
tein 1 light chain-3B (LC3B) (Chen et al., 2008, 2010). In
summary, there are numerous pathways involved in emphysema
pathogenesis. Utilizing transgenically modified mouse models
and pharmacological interventions, there have been significant
advances in the understanding of human disease pathogenesis
and treatment.
THE DEVELOPMENT OF EMPHYSEMA IS MOUSE STRAIN
DEPENDENT
One of the most important considerations in smoke exposure
studies is understanding that the development of emphysema in
a chronic smoke exposure model, as measured by morphometry
and lung compliance, is mouse strain dependent (Guerassimov
et al., 2004; Foronjy et al., 2005). In a comprehensive study per-
formed by Guerassimov and colleagues, NZWLac/J, C57BL6/J,
A/J, SJ/L, and AKR/J strains underwent 6 months of cigarette
smoke exposure. In morphometric analysis of emphysema, the
most impressive increase in mean linear intercept was observed
in the AKR/J strain (38% increase as compared to control
mice), with more modest increases seen in the A/J, SJ/L and
C57BL6/J mice (Guerassimov et al., 2004). The NZWLac/J mice
did not develop any increase in mean linear intercept (11%
decrease as compared to control mice) (Guerassimov et al., 2004).
Furthermore, despite detectible, albeit modest, alterations in lung
morphometry, there is not necessarily a correlation with alter-
ations in lungmechanics (Guerassimov et al., 2004; Foronjy et al.,
2005).
A difference in the inflammatory response explains at least
some of the variations between mouse strains in response to
chronic smoke exposure. Again, the AKR/J mice demonstrate
smoke-induced increases inmacrophages, PMNs, and T cells with
a Th1 cytokine predominance; increased alveolar macrophages
were also noted in the C57BL6/J and NZWLac/J mice (Foronjy
et al., 2005). In vitro analysis of alveolar macrophages from sus-
ceptible (C57BL6/J) and resistant (ICR) strains demonstrates that
alveolar macrophages from susceptible mice release increased
proinflammatory cytokines andMMPs when exposed to cigarette
smoke, and have a higher baseline production of reactive oxy-
gen species as compared to those obtained from resistant mice
(Vecchio et al., 2010). The pro-inflammatory early growth
response gene-1 (Egr-1) may provide some insight into strain
variation. Egr-1 induction by cigarette smoke varies by strain,
with marked increase in the emphysema-susceptible AKR/J mice
as compared to the relatively resistant NZWLac/J strain (Reynolds
et al., 2006).
It is important to understand that dissimilar to what is seen
in the human disease, in the mouse model of smoke-induced
emphysema, smoking cessation is accompanied by a reparative
response (Braber et al., 2011). Within 1 week of smoking ces-
sation, there is a partial normalization of MMP-2 and MMP-9
levels in BAL fluid (Seagrave et al., 2004), though lymphocyte
abnormalities including CD8 T cell oligoclonal expansions per-
sist (Seagrave et al., 2004; Motz et al., 2008). It is likely that
the combination of altered inflammatory response and cytokine
profiles are responsible for the variations between strains in
structural and functional measures of emphysema as well as for
the reparative response seen upon smoking cessation. However,
understanding the limitations of the mouse models has led our
group and others to investigate alternative animal models of
emphysema.
SMOKE EXPOSURE USING ALTERNATIVE ANIMAL SPECIES
While mice are the most widely utilized animal species for smoke
exposure studies, themouse model of emphysema has several lim-
itations. Mice do not express the same proteolytic repertoire upon
smoke exposure as humans. Mice do not even have the gene for
MMP-1, a key protease implicated in human emphysema patho-
genesis (D’Armiento et al., 1992). As stated above, mice develop
only mild structural and mechanical changes to the lung fol-
lowing smoke exposure (Foronjy et al., 2005). In addition, both
mice and rats undergo alveolar development entirely post-natally
(Massaro andMassaro, 2007). For these reasons and others, inves-
tigators have long been interested in identifying alternative animal
models of emphysema thatmore closelymimic the human disease
process.
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As opposed to rodents, the guinea pig model offers sev-
eral advantages that aid in the study of the effects of smoke
exposure. Guinea pigs begin lung alveolarization at birth, and
exhibit a progressive increase in air space size until 18 months
of age (Wright and Churg, 1990). The emphysema that guinea
pigs develop is easily recognizable (Golovatch et al., 2009), with
noted small airway remodeling and goblet cell metaplasia that
is absent in mouse exposure models (Wright and Sun, 1994;
Wright et al., 2007). Guinea pigs develop airway inflammation,
with increased alveolar macrophages as well as activation of the
MAP kinases ERK and JNK, as is seen in the human disease
state (Golovatch et al., 2009). In addition, as opposed to mice,
guinea pigs can develop significant pulmonary arterial hyperten-
sion after only 1 month of smoke exposure (Wright et al., 2006).
Most interestingly, in guinea pigs the development of emphy-
sema is cathepsin K dependent, as opposed to a metalloproteinase
or elastase driven lung destructive process, and while extracellu-
lar matrix changes similar to those in the human disease were
observed in the guinea pig smoke exposure model, there were
no noted alterations in collagenolytic MMPs (Golovatch et al.,
2009).
Furthermore, guinea pigs differ from mice in their repara-
tive responses following smoke exposure. While all-trans retinoic
acid treatment has proven to be useful in reversal of emphyse-
matous changes of alveolar structures in mice and rats (Massaro
and Massaro, 1997; Belloni et al., 2000), it does not produce
the same protective effects in smoke-exposed guinea pigs (Meshi
et al., 2002). Another major reparative response following smoke
exposure is the increase in matrix and structural cells in the
small airways and intrapulmonary arteries, but not in the alve-
olar wall. In both mice and guinea pigs, increased deposition of
collagen in the airway has been noted after chronic smoke expo-
sure (Churg et al., 2006, 2007). It is theorized that an increase
in apoptosis in emphysematous lungs could explain this failure
to repair in certain strains of mice, rats (Kasahara et al., 2000;
Tuder et al., 2003a), and humans (Kasahara et al., 2001). However,
our group has shown that certain strains of mice and guinea pigs
do not develop increased apoptosis with smoke exposure and
emphysema (Foronjy et al., 2005; Golovatch et al., 2009).
The rabbit smoke exposure model is another alternative to
the rodent models. Rabbits express MMP-1 and therefore the
macrophages express a protease repertoire similar to humans
(Fukuda et al., 2000). Studies have not only demonstrated the
presence of MMP-1 in the rabbit, but specifically MMP-1 expres-
sion during lung development is similar to human lung develop-
ment (Fukuda et al., 2000). Our group has recently demonstrated
that the smoke-exposed rabbit model exhibits the activation of
similar mechanistic pathways following smoke exposure as is
seen in the human disease (Geraghty et al., 2011a). Since it
is well-documented that MMP-1 is fundamental to emphysema
pathogenesis, the rabbit is the ideal species to examine when
exploring the MMP-1 regulated lung destruction and determin-
ing if pharmacological inhibition of MMP-1 is a feasible approach
to the treatment of emphysema.
Rabbits, similar to guinea pigs, differ from mice in their repar-
ative response to smoke exposure. In a study of rabbits exposed to
pine wood smoke, Thorning and colleagues document reparative
responses that include intact epithelial basal lamina acting as a
substratum for proliferating reparative epithelial cells (Thorning
et al., 1982). However, more recent studies have shown that
as opposed to mice the smoke-exposed rabbit does not exhibit
reversal of emphysematous changes after all-trans-retinoic acid
treatment (Nishi et al., 2003).
Both the rabbit and guinea pig models offer the specific
advantages over the rodent model as outlined above, but the dis-
advantages cannot go without mention. The large size and lack
of available reagents in rabbits and guinea pigs limit the ease of
experimentation. The high costs associated with purchase, hous-
ing, and smoke exposure in rabbits are practical deterrents to
their use. Furthermore, the lung destruction seen in the smoke-
exposed guinea pig model is cathepsin dependent, but cathepsins
do not play as significant a role in emphysema pathogenesis in
humans as MMPs (Golovatch et al., 2009).
Other alternative animal models for smoke exposure include
lambs and primates. In young lambs morphological changes in
the lung following second hand smoke exposure can appear after
a short period of time (<1 month) (Stecenko et al., 1986) mak-
ing it a useful model for smoke exposure studies. In addition, the
lungs of lambs are still developing after birth similar to humans,
and therefore the model is potentially useful for research into
the effects of second hand smoke on infant lung development.
Aside from the effects of cigarette smoke on the lung, lambs have
also been used to study the effect of passive smoke on laryngeal
chemoreflexes (St-Hilaire et al., 2010).
Non-human primate smoking models have been utilized to
demonstrate the effects of environmental smoke exposure with
studies focusing on infants, lung development, and pre vs. post-
natal effects. This model is particularly useful for studying the
effects of maternal smoke exposure during pregnancy (United
States. PublicHealth Service. Office of the Surgeon General, 2006)
as well as the carcinogenic effects of cigarette smoke (Coggins,
2001). Investigators have used a variety of smoke exposure meth-
ods with the primates including training non-human primates to
puff cigarettes (Ando and Yanagita, 1981). Unfortunately the pri-
mate model is difficult to work with secondary to regularity issues
and enormous costs.
The use of large animals including lambs and non-human
primates offer the advantage of more closely mimicking human
exposure, especially in prenatal and neonatal environments.
However, the disadvantages of all of the large animal models
include cost, size, and feasibility of smoke exposure studies, as well
as a lack of available reagents.
CONCLUSION
In conclusion, there is a substantial amount of information per-
tinent to second hand smoke exposure that can be gained from
an understanding of animal models of disease. It is important
to understand the limitations of each model of smoke exposure.
Rodents, while widely used, have several limitations, including
strain differences in disease susceptibility, and relatively mild
forms of emphysema. However, there is significant information
that can be gained from the use of mouse models, especially in
an era of transgenic manipulation. Themost attractive alternative
smoke exposure animal models are guinea pigs and rabbits,
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both developing clear evidence of inflammation and emphysema.
A better understanding of the benefits and drawbacks of these
models will assist researchers in best choosing the appropriate
species and exposure model prior to conducting smoke exposure
experiments.
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